Antiretroviral therapy for advanced naïve HIV-infected patients: current status and comparison of two different management strategiesMURPHY, Robert L.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 46, issn 1525-4135, 31 p., SUP1Serial Issue

HIV protease inhibitor-related lipodystrophy syndromeCARR, A.Clinical infectious diseases. 2000, Vol 30, pp S135-S142, issn 1058-4838, SUP2Article

Novel Antiretroviral Combinations in Treatment-Experienced Patients with HIV Infection: Rationale and ResultsTAIWO, Babafemi; MURPHY, Robert L; KATLAMA, Christine et al.Drugs (Basel). 2010, Vol 70, Num 13, pp 1629-1642, issn 0012-6667, 14 p.Article

Use of the transgenic mouse in models of AIDS cardiomyopathyLEWIS, William.AIDS (Supplement). 2003, Vol 17, pp S36-S45, issn 1350-2840, SUP1Article

Atherosclerosis and HIV in the highly active antiretroviral therapy era: towards an epidemic of cardiovascular disease?MOOSER, Vincent.AIDS (Supplement). 2003, Vol 17, pp S65-S69, issn 1350-2840, SUP1Article

Management of the adverse effects of antiretroviral therapy and medication adherenceMAX, B; SHERER, R.Clinical infectious diseases. 2000, Vol 30, pp S96-S116, issn 1058-4838, SUP2Article

Hiv lipodystrophy: risk factors, pathogenesis, diagnosis and managementCARR, Andrew.AIDS (Supplement). 2003, Vol 17, pp S141-S148, issn 1350-2840, SUP1Article

Factors affecting adherence to antiretroviral therapyCHESNEY, M. A.Clinical infectious diseases. 2000, Vol 30, pp S171-S176, issn 1058-4838, SUP2Article

HIV-1 protease inhibitorsERON, J. J.Clinical infectious diseases. 2000, Vol 30, pp S160-S170, issn 1058-4838, SUP2Article

Pathogenesis of HIV-associated heart diseaseBARBARO, Giuseppe.AIDS (Supplement). 2003, Vol 17, pp S12-S20, issn 1350-2840, SUP1Article

Resistance against reverse transcriptase inhibitorsO'BRIEN, W. A.Clinical infectious diseases. 2000, Vol 30, pp S185-S192, issn 1058-4838, SUP2Article

Using pharmacokinetics to optimize antiretroviral drug-drug interactions in the treatment of human immunodeficiency virus infectionGERBER, J. G.Clinical infectious diseases. 2000, Vol 30, pp S123-S129, issn 1058-4838, SUP2Article

Rationale for the use of hydroxyurea as an anti-human immunodeficiency virus drugLORI, F; LISZIEWICZ, J.Clinical infectious diseases. 2000, Vol 30, pp S193-S197, issn 1058-4838, SUP2Article

Comprehensive analysis of virus-specific T-cells provides clues for the failure of therapeutic immunization with ALVAC-HIV vaccinePAPAGNO, Laura; ALTER, Galit; ALTFELD, Marcus et al.AIDS (London). 2011, Vol 25, Num 1, pp 29-38, issn 0269-9370, 10 p.Article

Class-Sparing Regimens for Initial Treatment of HIV-1 InfectionRIDDLER, Sharon A; HAUBRICH, Richard; LALLOO, Umesh G et al.The New England journal of medicine. 2008, Vol 358, Num 20, pp 2095-2106, issn 0028-4793, 12 p.Article

Incidence of pancreatitis in HIV-1-infected individuals enrolled in 20 adult AIDS clinical trials group studies : Lessons learnedREISLER, Ronald B; MURPHY, Robert L; REDFIELD, Robert R et al.Journal of acquired immune deficiency syndromes (1999). 2005, Vol 39, Num 2, pp 159-166, issn 1525-4135, 8 p.Article

Long-term safety and durable antiretroviral activity of lopinavir/ritonavir in treatment-naive patients: 4 year follow-up study. CommentaryHICKS, Charles; KING, Martin S; KATZENSTEIN, David et al.AIDS (London). 2004, Vol 18, Num 5, pp 775-779, issn 0269-9370, 8 p.Article

Comparison of sequential three-drug regimens as initial therapy for HIV-1 infectionROBBINS, Gregory K; DE GRUTTOLA, Victor; GEDEON, Linda et al.The New England journal of medicine. 2003, Vol 349, Num 24, pp 2293-2303, issn 0028-4793, 11 p.Article

Mediators in HIV-associated cardiovascular disease: a focus on cytokines and genesFISHER, Stacy D; BOWLES, Neil E; TOWBIN, Jeffrey A et al.AIDS (Supplement). 2003, Vol 17, pp S29-S35, issn 1350-2840, SUP1Article

Influence of filgrastim (Granulocyte colony-stimulating factor) on human immunodeficiency virus type 1 RNA in patients with cytomegalovirus retinitisDAVIDSON, Michael; MIN, Yuan-I; HOLBROOK, Janet T et al.The Journal of infectious diseases. 2002, Vol 186, Num 7, pp 1013-1018, issn 0022-1899, 6 p.Article

Clinical utility of testing human immunodeficiency virus for drug resistanceHARRIGAN, P. R; COTE, H. C. F.Clinical infectious diseases. 2000, Vol 30, pp S117-S122, issn 1058-4838, SUP2Article

Optimal strategies for monitoring response to antiretroviral therapy in HIV-infected adults, adolescents, children and pregnant women: a systematic reviewTUCKER, Joseph D; BIEN, Cedric H; EASTERBROOK, Philippa J et al.AIDS (London). 2014, Vol 28, issn 0269-9370, S151-S160, SUP2Article

Interventions to improve adherence to antiretroviral therapy: a rapid systematic reviewCHAIYACHATI, Krisda H; OGBUOJI, Osondu; PRICE, Matthew et al.AIDS (London). 2014, Vol 28, issn 0269-9370, S187-S204, SUP2Article

Association of ongoing drug and alcohol use with non-adherence to antiretroviral therapy and higher risk of AIDS and death: results from ACTG 362COHN, Susan E; HONGYU JIANG; ALLEN MCCUTCHAN, J et al.AIDS Care (Print). 2011, Vol 23, Num 6, pp 775-785, issn 0954-0121, 11 p.Article

Change to atazanavir/ritonavir treatment improves lipids but not endothelial function in patients on stable antiretroviral therapyMURPHY, Robert L; BERZINS, Baiba; ZALA, Carlos et al.AIDS (London). 2010, Vol 24, Num 6, pp 885-890, issn 0269-9370, 6 p.Article